Two years into the COVID-19 pandemic, there is evidence that pregnant women are more vulnerable to the SARS-CoV-2 coronavirus that causes COVID-19.
However, little is known about the possible consequences for an unborn child if the mother is infected with SARS-CoV-2 during pregnancy.
And the likelihood and impact of vertical transmission, meaning the passage of the virus from the mother to the fetus, remains unclear.
Baby’s Brain Unharmed by SARS-CoV-2 Infection
Omicron Variant Travel Advice Issued
The World Health Organization (WHO) confirmed today an increasing number of countries are introducing temporary travel measures, including temporarily prohibiting the arrival of international travelers from South African countries and others.
These travel bans are related to the variant of concern (VOC) named Omicron.
The WHO calls on all countries to follow the IHR (2005) and show global solidarity in rapid and transparent information sharing in response to Omicron.
Omicron Variant May Circumvent COVID-19 Antibody Cocktails
A leader in producing monoclonal antibody treatments confirmed today ‘there have been no direct in-clinic data testing against the SARS-CoV-2 virus variant known as Omicron.’
In today’s press release, New York-based Regeneron Inc. stated that the company is evaluating REGEN-COV® against the Omicron (B.1.1.529) variant.
Omicron Variant Spurs New York Officials to Recommend Masking Indoors
So far, there are no confirmed cases of the omicron variant in New York City, according to the health commissioner
FDA Panel Mulls Merck COVID-19 Antiviral Pill
Expert panel will vote later Tuesday on whether to recommend authorizing the drug for high-risk patients
Colchicine No Benefit Over Supportive Care for COVID-19
No significant reduction reported in mortality, ventilatory support, ICU admission, length of stay, serious adverse events; increase seen in adverse events, diarrhea
Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
No direct data yet available testing the new variant’s resistance to immunity from monoclonal antibodies and vaccines
Thanksgiving Weekend Brought New COVID-19 Concerns: the Omicron Variant
On Saturday, the CDC issued a statement stressing that ‘no cases of this variant have been identified in the U.S. to date’
Decline in Infectious Conjunctivitis During COVID-19 Pandemic
Decrease in emergency department encounters for nonallergic conjunctivitis after adoption of public health measures to curb COVID-19
Merck’s COVID-19 Pill Appears Effective, but May Pose Pregnancy Risks: FDA
Given safety concerns, FDA scientists said Merck has agreed the drug will not be used in children.